4078.T
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
The company maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.28, indicating a low reliance on debt financing. Its liquidity position is characterized by a current ratio of 2.56, suggesting the company has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
Profitability metrics show a return on equity (ROE) of 6.41% and a return on assets (ROA) of 4.07%, both below the typical thresholds for high-performing chemical firms. The company's gross profit margin is 24.02% (20,282 million JPY gross profit on 84,409 million JPY revenue), and its operating margin is 6.47% (5,463 million JPY operating income on 84,409 million JPY revenue), which is in line with the industry median for Commodity Chemicals.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's revenue is primarily derived from the sale of chemical products, with no material contribution from other business lines.
Looking ahead, the company is projected to experience modest revenue growth, with a current FY outlook of 1.5% and a next FY outlook of 2.0%. These growth rates are in line with the industry average for Commodity Chemicals, which is driven by stable demand in industrial and manufacturing sectors.
The company faces moderate risk from liquidity constraints, as noted by the negative net cash position after subtracting total debt. While the dilution risk is currently low, the company has not disclosed any recent share issuance or dilution events. The absence of dilution activity suggests a stable capital structure, but the company may need to raise additional capital if liquidity pressures persist.
Recent events include a strong analyst recommendation with a mean score of 1.00, indicating a strong buy consensus. The last actual EPS of 309.21 JPY exceeded the mean EPS estimate of 191.20 JPY, suggesting the company is outperforming expectations. No recent filings or transcripts have been disclosed that would indicate significant operational or strategic changes.
- The company has a conservative capital structure with a low debt-to-equity ratio of 0.28.
- Profitability metrics are in line with industry medians, with an ROE of 6.41% and an ROA of 4.07%.
- Revenue is concentrated in a single business segment, increasing exposure to regional and sector-specific risks.
- Analysts have a strong buy consensus, with the last actual EPS exceeding estimates.
- The company faces moderate liquidity risk due to a negative net cash position after subtracting total debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 191,20 |
| Revenue | —no estimate | —no estimate | 82,2B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 4078.T Market data — financials · 2026-05-26
- Sakai Chemical Industry Co Ltd Market data — analyst estimates · 2026-05-26